These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36645381)

  • 21. A combinatorial approach for achieving CNS-selective RNAi.
    Ferguson CM; Godinho BMDC; Echeverria D; Hassler M; Vangjeli L; Sousa J; McHugh N; Alterman J; Hariharan V; Krishnamurthy PM; Watts J; Rogaev E; Khvorova A
    Nucleic Acids Res; 2024 May; 52(9):5273-5284. PubMed ID: 38348876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies for in vivo delivery of siRNAs: recent progress.
    Higuchi Y; Kawakami S; Hashida M
    BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A dual therapeutic system based on corrole-siRNA conjugates.
    Giorgees I; Wu F; Shen Z; Desaulniers JP
    Org Biomol Chem; 2022 Mar; 20(13):2626-2635. PubMed ID: 35147149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
    Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
    Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells.
    Raof NA; Rajamani D; Chu HC; Gurav A; Johnson JM; LoGerfo FW; Pradhan-Nabzdyk L; Bhasin M
    BMC Genomics; 2016 Jan; 17():20. PubMed ID: 26728506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel siRNA validation system for functional screening and identification of effective RNAi probes in mammalian cells.
    Hung CF; Lu KC; Cheng TL; Wu RH; Huang LY; Teng CF; Chang WT
    Biochem Biophys Res Commun; 2006 Aug; 346(3):707-20. PubMed ID: 16793020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery and enhanced gene-silencing activity of centrally modified folic acid-siRNA conjugates.
    Salim L; Islam G; Desaulniers JP
    Nucleic Acids Res; 2020 Jan; 48(1):75-85. PubMed ID: 31777918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
    Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoinduced RNA interference.
    Matsushita-Ishiodori Y; Ohtsuki T
    Acc Chem Res; 2012 Jul; 45(7):1039-47. PubMed ID: 22360585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
    De Paula D; Bentley MV; Mahato RI
    RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure Tuning of Cationic Oligospermine-siRNA Conjugates for Carrier-Free Gene Silencing.
    Nothisen M; Bagilet J; Behr JP; Remy JS; Kotera M
    Mol Pharm; 2016 Aug; 13(8):2718-28. PubMed ID: 27398779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of 2'-O-guanidinopropyl-modified nucleoside phosphoramidites and their incorporation into siRNAs targeting hepatitis B virus.
    Brzezinska J; D'Onofrio J; Buff MC; Hean J; Ely A; Marimani M; Arbuthnot P; Engels JW
    Bioorg Med Chem; 2012 Feb; 20(4):1594-606. PubMed ID: 22264759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DEQOR: a web-based tool for the design and quality control of siRNAs.
    Henschel A; Buchholz F; Habermann B
    Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W113-20. PubMed ID: 15215362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of thiophosphate substitutions on native siRNA gene silencing.
    Li ZY; Mao H; Kallick DA; Gorenstein DG
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1026-30. PubMed ID: 15752758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
    Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
    Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular Delivery of siRNAs Using Bolaamphiphiles.
    Gupta K
    Methods Mol Biol; 2017; 1632():187-205. PubMed ID: 28730440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoregulation of Gene Expression with Amantadine-Modified Caged siRNAs through Host-Guest Interactions.
    Zhang J; Jing N; Fan X; Tang X
    Chemistry; 2020 Nov; 26(61):14002-14010. PubMed ID: 32678486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comprehensive update of siRNA delivery design strategies for targeted and effective gene silencing in gene therapy and other applications.
    Abosalha AK; Ahmad W; Boyajian J; Islam P; Ghebretatios M; Schaly S; Thareja R; Arora K; Prakash S
    Expert Opin Drug Discov; 2023 Feb; 18(2):149-161. PubMed ID: 36514963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potency of siRNA-mediated growth inhibition following silencing of essential genes is dependent on siRNA design and varies with target sequence.
    Patel R; T'wallant NC; Herbert MH; White D; Murison JG; Reid G
    Oligonucleotides; 2009 Dec; 19(4):317-28. PubMed ID: 19943803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.